ConductScience.org, home

Paper29761997

[Research progress on characteristics and applications of melanin nanoparticles].

Yang L and 6 others. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2017. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. [Research progress on characteristics and applications of melanin nanoparticles]. Papers, record 29761997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29761997

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Research progress on characteristics and applications of melanin nanoparticles].
PubMed
Journal
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
PubMed
Year
2017
PubMed
Publication types
English Abstract, Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.08
iCite
Revised in PubMed
2023-07-02
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang LLiu
2Zhao YYinghu
3Wang FFang
4Liu HHaiying
5Li QQinqin
6Wang LLinbian
7Gao LLi

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128595014Chelator-Free and Biocompatible Melanin Nanoplatform with Facile-Loading Gadolinium and Copper-64 for Bioimaging.Bioconjug Chem2017https://conductscience.org/library/papers/28595014PubMed
218848901Ionizing radiation: how fungi cope, adapt, and exploit with the help of melanin.Curr Opin Microbiol2008https://conductscience.org/library/papers/18848901PubMed
324768404Natural melanin: a potential pH-responsive drug release device.Int J Pharm2014https://conductscience.org/library/papers/24768404PubMed
430034730Recyclable Cu(i)/melanin dots for cycloaddition, bioconjugation and cell labelling.Chem Sci2016https://conductscience.org/library/papers/30034730PubMed
523987128Bio-inspired, melanin-like nanoparticles as a highly efficient contrast agent for T1-weighted magnetic resonance imaging.Biomacromolecules2013https://conductscience.org/library/papers/23987128PubMed
621319809Bioinspired polymerization of dopamine to generate melanin-like nanoparticles having an excellent free-radical-scavenging property.Biomacromolecules2011https://conductscience.org/library/papers/21319809PubMed
727173400Artificial pheomelanin nanoparticles and their photo-sensitization properties.J Photochem Photobiol B2016https://conductscience.org/library/papers/27173400PubMed
825292385Transferring biomarker into molecular probe: melanin nanoparticle as a naturally active platform for multimodality imaging.J Am Chem Soc2014https://conductscience.org/library/papers/25292385PubMed
925300618Melanin nanoparticles (MNPs) provide protection against whole-body ɣ-irradiation in mice via restoration of hematopoietic tissues.Mol Cell Biochem2015https://conductscience.org/library/papers/25300618PubMed
1027311820Melanin and neuromelanin binding of drugs and chemicals: toxicological implications.Arch Toxicol2016https://conductscience.org/library/papers/27311820PubMed
1125893172Melanin nanoparticles as a novel contrast agent for optoacoustic tomography.Photoacoustics2015https://conductscience.org/library/papers/25893172PubMed
1225412570Transformation of cell-derived microparticles into quantum-dot-labeled nanovectors for antitumor siRNA delivery.Angew Chem Int Ed Engl2015https://conductscience.org/library/papers/25412570PubMed
1326275860Dragon fruit-like biocage as an iron trapping nanoplatform for high efficiency targeted cancer multimodality imaging.Biomaterials2015https://conductscience.org/library/papers/26275860PubMed
1423280690Dopamine-melanin colloidal nanospheres: an efficient near-infrared photothermal therapeutic agent for in vivo cancer therapy.Adv Mater2013https://conductscience.org/library/papers/23280690PubMed
1526222210Engineering Melanin Nanoparticles as an Efficient Drug-Delivery System for Imaging-Guided Chemotherapy.Adv Mater2015https://conductscience.org/library/papers/26222210PubMed
1627750002Superior Performance of Polyurethane Based on Natural Melanin Nanoparticles.Biomacromolecules2016https://conductscience.org/library/papers/27750002PubMed
1726887341Antioxidant activity of a Lachnum YM226 melanin-iron complex and its influence on cytokine production in mice with iron deficiency anemia.Food Funct2016https://conductscience.org/library/papers/26887341PubMed
1827031812Melanin nanoparticles derived from a homology of medicine and food for sentinel lymph node mapping and photothermal in vivo cancer therapy.Biomaterials2016https://conductscience.org/library/papers/27031812PubMed
1926847879Salt-induced aggregation of gold nanoparticles for photoacoustic imaging and photothermal therapy of cancer.Nanoscale2016https://conductscience.org/library/papers/26847879PubMed
2027782375Water Soluble Melanin Derivatives for Dynamic Contrast Enhanced Photoacoustic Imaging of Tumor Vasculature and Response to Antiangiogenic Therapy.Adv Healthc Mater2017https://conductscience.org/library/papers/27782375PubMed

See all 28 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29761997

GET https://conductscience.org/api/papers/v1/29761997/references?page=2